Furthermore, ASP stimulates insulin release from the pancreas, therefore the decrease in insulin level in CF may be associated not only with pancreatic damage, but also with a decrease in ASP levels in patients with CF-related diabetes (7, 34). This evidence concerns the gene INS and diabetes mellitus.